Elite Pharmaceuticals, Inc. Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock
Elite Pharmaceuticals, Inc. (ELTP) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock of 142.86 million shares for the 12-month period ending 2015-03-31, per its 10-K filed 2016-06-15.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock · last filed 2016-06-15
- Elite Pharmaceuticals, Inc. incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2015 was 142.86M shares, a 4.07% decline from fiscal 2014.
- Elite Pharmaceuticals, Inc. incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2014 was 148.92M shares, a 78.90% increase from fiscal 2013.
- Elite Pharmaceuticals, Inc. incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2013 was 83.24M shares, a 11.93% decline from fiscal 2012.
- Elite Pharmaceuticals, Inc. incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2012 was 94.51M shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 12 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 12 month as first filed |
|---|---|---|
| 2015-03-31 | 142.86M shares 10-K · filed 2016-06-15 | |
| 2014-03-31 | 148.92M shares 10-K · filed 2015-06-15 | |
| 2013-03-31 | 83.24M shares 10-K · filed 2014-06-30 | 0.00 shares 10-K · filed 2013-06-21 |
| 2012-03-31 | 94.51M shares 10-K · filed 2013-06-21 |